Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways
Francesca Crudele,
Nicoletta Bianchi,
Anna Terrazzan,
Pietro Ancona,
Antonio Frassoldati,
Paolo Gasparini,
Adamo P. D’Adamo,
Dimitrios Papaioannou,
Ramiro Garzon,
Anna Wójcicka,
Paweł Gaj,
Krystian Jażdżewski,
Jeffrey Palatini,
Stefano Volinia
Affiliations
Francesca Crudele
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy
Nicoletta Bianchi
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy
Anna Terrazzan
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy
Pietro Ancona
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy
Antonio Frassoldati
Department of Oncology, Azienda Ospedaliero-Universitaria St. Anna di Ferrara, 44124 Ferrara, Italy
Paolo Gasparini
Genetics Unit, Institute for Maternal and Child Health, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) Burlo Garofolo, 34137 Trieste, Italy
Adamo P. D’Adamo
Genetics Unit, Institute for Maternal and Child Health, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) Burlo Garofolo, 34137 Trieste, Italy
Dimitrios Papaioannou
Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, NYU Langone Health, New York, NY 10016, USA
Ramiro Garzon
Division of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, UT 84112, USA
Anna Wójcicka
Warsaw Genomics INC, 01-682 Warszawa, Poland
Paweł Gaj
Warsaw Genomics INC, 01-682 Warszawa, Poland
Krystian Jażdżewski
Human Cancer Genetics, Biological and Chemical Research Centre, University of Warsaw, 02-089 Warsaw, Poland
Jeffrey Palatini
Genomics Core Facility, Centre of New Technologies, University of Warsaw, 02-097 Warsaw, Poland
Stefano Volinia
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy
circRNAs constitute a novel class of RNA, generally considered as non-coding RNAs; nonetheless, their coding potential has been under scrutiny. In this work, we systematically explored the predicted proteins of more than 160,000 circRNAs detected by exome capture RNA-sequencing and collected in the MiOncoCirc pan-cancer compendium, including normal and cancer samples from different types of tissues. For the functional evaluation, we compared their primary structure and domain composition with those derived from the same linear mRNAs. Among the 4362 circRNAs potentially encoding proteins with a unique primary structure and 1179 encoding proteins with a novel domain composition, 183 were differentially expressed in cancer. In particular, eight were associated with prognosis in acute myeloid leukemia. The functional classification of the dysregulated circRNA-encoded polypeptides showed an enrichment in the heme and cancer signaling, DNA-binding, and phosphorylation processes, and disclosed the roles of some circRNA-based effectors in cancer.